Drug Administration: Emergency approval of 16 new coronary vaccine varieties for clinical trials

Pharmaceutical Network February 20, the State Drug Administration, the head of the Department of Policy and Regulation, said in response to a reporter's question, at present, has conditions approved China's two new coronavirus vaccine market, emergency approval of 5 technical routes a total of 16 vaccine varieties to carry out clinical trials, of which 6 vaccine varieties have been carried out Phase III clinical trials.
February 19, the Supreme People's Procuratorate, the State Administration of Market Supervision and Administration and the State Drug Administration jointly issued 15 typical cases of special actions to implement the "four most stringent" requirements for food and drug safety.
questions related to the "four most stringent" special actions, the head of the Fourth Prosecutor's Office of the Supreme People's Procuratorate, the Law Enforcement Inspection Bureau of the State Administration of Market Supervision and Administration, and the Policy and Regulation Department of the State Drug Administration answered questions from reporters.
the three departments have taken measures during the prevention and control of the new crown epidemic? In response, the head of the policy and regulation department of the State Drug Administration said that the State Drug Administration organized the prevention and control of the epidemic drug equipment centralized rectification, actively promote the development and listing of the new coronavirus vaccine, do a good job in the new coronary pneumonia treatment drugs and medical protective medical device emergency approval, take the initiative to connect the relevant production enterprises, complete the registration test, review, for the new coronavirus vaccine mass production preparation.
and strict quality control, strengthen risk management, send steering groups to key provinces on the quality of medical materials special supervision.
According to its introduction, at present, a total of 22 drugs have been approved for treatment and prevention clinical trials of neo-coronary pneumonia and its related adaptations;
all over the emergency approval of medical protective clothing registration certificate 420, medical protective mask registration certificate 307.
has conditionly approved the listing of 2 new coronavirus vaccines in China, and has approved a total of 16 vaccine varieties in 5 technical routes for clinical trials, of which 6 vaccine varieties have been conducted in Phase III clinical trials.